Welcome to The Script
Your trusted source for supplement education
View past issues
July 2024 – The women’s health series (part 1 of 2): Women’s cardiometabolic and hormonal health
This issue of The Script focuses on women’s cardiometabolic and hormonal health. We cover protocols for these health issues and discuss quality concerns of prenatal multivitamins. We explore how hypertension relates to uterine fibroids, the impact of the gut microbiota on endometriosis, and how essential amino acid supplementation improves hepatic steatosis in adolescents with PCOS and obesity. We also discuss key supplements such as collagen peptides, CurcuRouge®, creatine monohydrate, and pasteurized Akkermansia muciniphila.
June 2024 – The cardiometabolic series (part 3 of 3): Weight management
In the final issue of The Script‘s cardiometabolic series we cover weight management and metabolic health. We feature new GLP-1 protocols and examine the quality concerns of weight loss supplements. Other topics include early time-restricted eating, youth overnutrition, and the benefits of apple cider vinegar. Additionally, we introduce Amarasate® and discuss AI’s role in healthcare.
May 2024 – The cardiometabolic series (part 2 of 3): Cardiovascular risk factors
The second issue of The Script’s cardiometabolic series addresses cardiovascular risk factors, including endothelial health, cholesterol, blood pressure, and glycemic control. We feature new protocols from OvationLab and Fullscript, quality concerns about fish oil supplements, and studies exploring the impact of vitamin D and green tea on cardiometabolic health. Other highlights include innovative ingredients like Healthberry® and Vascanox HP®, as well as the use of nitric oxide test strips in patient care.
April 2024 – The cardiometabolic series (part 1 of 3): GLP-1 and metabolic health
The first issue of The Script’s cardiometabolic series focuses on GLP-1 and metabolic health. We discuss the potential side effects associated with GLP-1 agonist use as well as supplement ingredients shown to support GLP-1 production. We address quality concerns regarding berberine supplements and provide protocols for managing post-bariatric surgery nutritional deficiencies and supporting blood sugar homeostasis.
March 2024 – The gastrointestinal and gut microbiome series (part 3 of 3)
In this third and final issue of The Script‘s gastrointestinal and gut microbiome series, we explore the impact of probiotics on bone resorption in postmenopausal women and prebiotics’ potential cognitive benefits. We examine low-no-calorie sweeteners’ effects on gut microbiota, quality concerns with magnesium supplements, and pesticide exposure in medicinal herbs. Finally, we highlight the innovative strains Limosilactobacillus reuteri DSM 17648 and Bacillus coagulans Unique IS2.
February 2024 – The gastrointestinal and gut microbiome series (part 2 of 3)
Continuing our series on gastrointestinal and gut microbiome health, this edition explores Dr. Michael Ruscio’s insights on probiotics for small intestinal bacterial overgrowth (SIBO) and new research on the gut-lung axis. We address quality concerns with fish oil supplements and introduce ingredients like Akkermansia muciniphila, DS-01®, and VSL#3®.
January 2024 – The gastrointestinal and gut microbiome series (part 1 of 3)
In this inaugural edition, we explore innovations in gastrointestinal and gut microbiome health. Highlights include the FDA’s warning to Amazon about tainted supplements and Pendulum’s discussion on gut microbiome on The Peter Attia Drive podcast. We also explore the potential role of microbiota in social anxiety and introduce the following innovative ingredients: live Akkermansia municiphila, Bifidobacterium longum strains, and human milk oligosaccharides (HMOs).